CAR consists of extracellular single chain variable fragments targeting multiple tumor-associated antigens (TAAs), an intracellular CD3 region, a transmembrane segment, and a costimulatory domain, such as the intracellular domains of CD28 or CD3ζ plus 4-1BB (76). This evidence concerns the gene CD247 and neoplasm.